CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $795
- in 4 filings, $795 under 10b5-1 plans
Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-13 | Kim Lorence H. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-06-13 | Pomerantz Roger Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-06-13 | AFEYAN NOUBAR Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-06-13 | Dere Willard H Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-06-13 | Behar Gregory Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-06-13 | Graves Kurt Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-06-13 | Kender Richard N Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-06-13 | Ausiello Dennis A Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-06-13 | Zausner Meryl Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-01-28 | DesRosier Thomas Chief Legal Officer and EVP | Sale | −5,471 | $5.75 | $31K | 16,054 |
| 2019-01-28 | Shaff Eric D. | Sale | −4,378 | $5.75 | $25K | 12,842 |
| 2019-01-26 | DesRosier Thomas Chief Legal Officer and EVP | Exercise or conversion | +15,000 | 21,525 | ||
| 2019-01-26 | DesRosier Thomas Chief Legal Officer and EVP | Exercise or conversion · RESTRICTED STOCK UNITS | −15,000 | 25,000 | ||
| 2019-01-26 | Shaff Eric D. | Exercise or conversion | +12,000 | 17,220 | ||
| 2019-01-26 | Shaff Eric D. | Exercise or conversion · RESTRICTED STOCK UNITS | −12,000 | 20,000 | ||
| 2019-01-26 | Aunins John G. Chief Technology Officer | Exercise or conversion | +7,500 | 92,750 | ||
| 2019-01-26 | Aunins John G. Chief Technology Officer | Exercise or conversion · RESTRICTED STOCK UNITS | −7,500 | 12,500 | ||
| 2019-01-26 | COOK DAVID N | Exercise or conversion | +7,500 | 147,435 | ||
| 2019-01-26 | COOK DAVID N | Exercise or conversion · RESTRICTED STOCK UNITS | −7,500 | 12,500 | ||
| 2019-01-25 | HORGAN KEVIN Chief Medical Officer and EVP | Grant or award · STOCK OPTION (RIGHT TO BUY) | +30,000 | 30,000 |
Page 25 of 34 · 662 trades